Impact of the 2008 US preventive services task force recommendation to discontinue prostate cancer screening among male medicare beneficiaries

Archives of Internal Medicine

Volumn 172, Issue 20, 2012, Pages 1601-1603

  Ross, Joseph S ^a,b   Wang, Rong ^a,b   Long, Jessica B ^a,b   Gross, Cary P ^a,b   Ma, Xiaomei ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER;

ADVISORY COMMITTEES; AGED; EARLY DETECTION OF CANCER; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; MALE; MASS SCREENING; MEDICARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84869100867     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.3726     Document Type: Article

References (9)

1. Moyer VA; US Preventive Services Task Force. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement [published online May 21, 2012]. Ann Intern Med . doi:10.7326 /0003-4819-157-2-201207170- 00464.
2. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149(3):185-191.
3. National Cancer Institute. Surveillance Epidemiology and End Results. http: //seer.cancer.gov/. Accessed December 28, 2011.
4. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336-2342. (Pubitemid 44749361)
5. Bynum J, Song Y, Fisher E. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc. 2010; 58(4):674-680.
6. Dartmouth Atlas of Health Care. Atlas Downloads. http://www. dartmouthatlas .org/tools/downloads.aspx. Accessed February 6, 2012.
7. Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 2011;103(6):520-523.
8. Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA. 2012;307(16):1692-1694.
9. Scosyrev E, Wu G, Golijanin D, Messing E. Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system [published online March 27, 2012]. BJU Int. doi:10.1111/j.1464-410X .2012.11013.x.